Home › Neoplasms by Histologic Type › Iowa › Cedar Rapids
Neoplasms by Histologic Type clinical trials in Cedar Rapids, IA
3 studies for Neoplasms by Histologic Type are looking for participants at sites in and around Cedar Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- University of Iowa, Iowa City · 25 mi away
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RecruitingObservational study
- The State University of Iowa, Iowa City · 25 mi away
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- University of Iowa Hospitals & Clinics, Iowa City · 25 mi away
Neoplasms by Histologic Type trials in other cities
- Boston, MA5 studies
- Chicago, IL5 studies
- Houston, TX4 studies
- Atlanta, GA4 studies
- Los Angeles, CA4 studies
- St. Louis, MO4 studies
- Nashville, TN3 studies
- Dallas, TX3 studies
- San Francisco, CA3 studies
- Clifton, NJ3 studies
- New York City, NY3 studies
- Tampa, FL3 studies
Other studies in Cedar Rapids
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer17 studies
- Cancer (all types)17 studies
- Lung Cancer17 studies
- Multiple Myeloma16 studies
- Acute Myeloid Leukemia15 studies
- Colorectal Cancer14 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Prostate Cancer12 studies
- Melanoma11 studies
- Metastatic Cancer9 studies
- Blood Cancers9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.